Comprehensive characterization of HER2-low breast cancers: implications in prognosis and treatment

BACKGROUND: HER2-low cancers are heterogeneous with different degrees of HER2 expression and hormone receptor (HR) status. Currently, its analysis is mostly focused on the standard clinic-pathologic features or common biomarkers expression, without considering the heterogeneity within the category....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuyang, Tsang, Julia Y., Tam, Fiona, Loong, Thomson, Tse, Gary M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130469/
https://www.ncbi.nlm.nih.gov/pubmed/37068349
http://dx.doi.org/10.1016/j.ebiom.2023.104571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130469/
https://www.ncbi.nlm.nih.gov/pubmed/37068349
http://dx.doi.org/10.1016/j.ebiom.2023.104571

Ejemplares similares